Exosens Shares Dip at Opening Despite Stifel Upgrade
Exosens shares fell by 1.82% on Wednesday morning, February 4th, settling at 53.90 euros. This downward movement comes even though the specialist in light amplification and high-performance detectors has shown an annual increase of 134.5%.
Stifel Significantly Raises Price Target on Exosens
On February 3rd, the analysis firm Stifel substantially raised its price target on Exosens from 47 to 60 euros, while maintaining a 'buy' recommendation. This revision gives the stock a potential upside of more than 11% from its current price. Another financial institution also supports the case: Bernstein initiated coverage on January 19 with an 'outperform' rating and a target of 71 euros, valuing the stock with a potential rise of over 31% from current levels.
Technical Analysis of Exosens
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
From a technical analysis standpoint, Exosens is trading above its main moving averages, with the stock priced at 53.90 euros compared to a 50-day moving average of 49.70 euros and a 200-day average of 43.71 euros. This setup indicates a favorable medium and long-term trend. However, the Relative Strength Index (RSI) is at 39, indicating a short-term relative weakness without reaching an oversold level. The stock remains distant from its major resistance threshold set at 58.30 euros, while the technical support is lower, at 46.45 euros. The stock's monthly volatility stands at 10.27%, reflecting significant price variations over this period.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
